MeSH tree: C08.381.540.140.500
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study, published in the International Journal of Molecular Science and led by Goll-Ohio ...
Mar 2, 2026
0
13
A research team led by Professor Ki-Young Lee at the College of Medicine, Sungkyunkwan University, has uncovered a previously unrecognized tumor-intrinsic role of the immune checkpoint molecule PD-L1, providing new mechanistic ...
Feb 26, 2026
0
4
Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, helping explain why many patients do not respond to immunotherapy and pointing to a potential new ...
Feb 19, 2026
0
67
Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published in Nature Aging this ...
Feb 13, 2026
0
29
For adults with clinically node-negative non-small cell lung cancer (NSCLC), assessment of more than one N1 nodal station is associated with increased nodal upstaging and improved survival, according to a study presented ...
Feb 7, 2026
0
6
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found cell metabolism plays a critical role in determining how lung cancer patients will respond to immunotherapy. ...
Feb 3, 2026
0
8
Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease progression than patients receiving treatment later in the day. The findings, published as part of a randomized ...
Feb 2, 2026
0
39
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to accurately identify cancer ...
Jan 31, 2026
0
6
Following the 2018 federal expansion of short-term limited-duration (STLD) insurance plans, limited or no state regulation of plans was associated with decreases in timely cancer treatment initiation, according to a study ...
Jan 29, 2026
0
7
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.
Jan 22, 2026
0
10
